Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Global Cardiovascular and… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Global Cardiovascular and Renal Outcomes of Reduced GFR

Artikel i vetenskaplig tidskrift
Författare B. Thomas
K. Matsushita
K. H. Abate
Z. Al-Aly
J. Amlov
K. Asayama
R. Atkins
A. Badawi
S. H. Ballew
A. Banerjee
Lars Barregård
E. Barrett-Connor
S. Basu
A. K. Bello
I. Bensenor
J. Bergstrom
B. Bikbov
C. Blosser
H. Brenner
J. J. Carrero
S. Chadban
M. Cirillo
M. Cortinovis
K. Courville
L. Dandona
R. Dandona
K. Estep
J. Fernandes
F. Fischer
C. Fox
R. T. Gansevoort
P. N. Gona
O. M. Gutierrez
S. Hamidi
S. W. Hanson
J. Himmelfarb
S. K. Jassal
S. H. Jee
V. Jha
A. Jimenez-Corona
J. B. Jonas
A. P. Kengne
Y. Khader
Y. H. Khang
Y. J. Kim
B. Klein
R. Klein
Y. Kokubo
D. Kolte
K. Lee
A. S. Levey
Y. M. Li
P. Lotufo
H. M. Abd El Razek
W. Mendoza
H. Metoki
Y. Mok
I. Muraki
P. M. Muntner
H. Noda
T. Ohkubo
A. Ortiz
N. Perico
K. Polkinghorne
R. Al-Radaddi
G. Remuzzi
G. Roth
D. Rothenbacher
M. Satoh
K. U. Saum
M. Sawhney
B. Schottker
A. Shankar
M. Shlipak
D. A. S. Silva
H. Toyoshima
K. Ukwaja
M. Umesawa
S. E. Vollset
D. G. Warnock
A. Werdecker
K. Yamagishi
Y. Yano
N. Yonemoto
M. E. Zaki
M. Naghavi
M. H. Forouzanfar
C. J. L. Murray
J. Coresh
T. Vos
G. F. R. Collabo C. K. D. Prognosis Consortium Global Burden Dis Genitourinary Ex Global Burden Dis
Publicerad i Journal of the American Society of Nephrology
Volym 28
Nummer/häfte 7
Sidor 2167-2179
ISSN 1046-6673
Publiceringsår 2017
Publicerad vid Institutionen för medicin, avdelningen för samhällsmedicin och folkhälsa
Sidor 2167-2179
Språk en
Länkar doi.org/10.1681/asn.2016050562
Ämnesord chronic kidney-disease, glomerular-filtration-rate, collaborative, metaanalysis, mesoamerican nephropathy, maintenance dialysis, population, cohorts, general-population, heart-disease, all-cause, risk, Urology & Nephrology, ettine.os, 1974, american journal of epidemiology, v99, p325
Ämneskategorier Klinisk medicin

Sammanfattning

The burden of premature death and health loss from ESRD is well described. Less is known regarding the burden of cardiovascular disease attributable to reduced GFR. We estimated the prevalence of reduced GFR categories 3, 4, and 5 (not on RRT) for 188 countries at six time points from 1990 to 2013. Relative risks of cardiovascular outcomes by three categories of reduced GFR were calculated by pooled random effects meta-analysis. Results are presented as deaths for outcomes of cardiovascular disease and ESRD and as disability-adjusted life years for outcomes of cardiovascular disease, GFR categories 3, 4, and 5, and ESRD. In 2013, reduced GFR was associated with 4% of deaths worldwide, or 2.2 million deaths (95% uncertainty interval [95% UI], 2.0 to 2.4 million). More than half of these attributable deaths were cardiovascular deaths (1.2 million; 95% UI, 1.1 to 1.4 million), whereas 0.96 million (95% UI, 0.81 to 1.0 million) were ESRD-related deaths. Compared with metabolic risk factors, reduced GFR ranked below high systolic BP, high body mass index, and high fasting plasma glucose, and similarly with high total cholesterol as a risk factor for disability-adjusted life years in both developed and developing world regions. In conclusion, by 2013, cardiovascular deaths attributed to reduced GFR outnumbered ESRD deaths throughout the world. Studies are needed to evaluate the benefit of early detection of CKD and treatment to decrease these deaths.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?